These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 20091835

  • 1. A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
    Hortobagyi GN, Heim W, Hutchins L, Rivera E, Mason B, Booser DJ, Kirshner J.
    Cancer; 2010 Mar 15; 116(6):1440-5. PubMed ID: 20091835
    [Abstract] [Full Text] [Related]

  • 2. A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
    Hortobagyi GN, Young RR, Karwal M, Ibrahim NK, Hermann R, Murray JL, Watkins SP, Gore I.
    Cancer; 2010 May 15; 116(10):2301-6. PubMed ID: 20225231
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.
    Cancer; 2001 Jun 15; 91(12):2288-93. PubMed ID: 11413517
    [Abstract] [Full Text] [Related]

  • 4. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P.
    Cancer; 1996 Jul 15; 78(2):211-6. PubMed ID: 8673994
    [Abstract] [Full Text] [Related]

  • 5. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
    Lin PC, Chen WS, Chao TC, Yang SH, Tiu CM, Liu JH.
    Cancer Chemother Pharmacol; 2007 Aug 15; 60(3):351-6. PubMed ID: 17111120
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL.
    J Clin Oncol; 2004 Sep 01; 22(17):3466-74. PubMed ID: 15277535
    [Abstract] [Full Text] [Related]

  • 7. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A, García-Berrocal MI, Arias F, Mariño A, Valcárcel F, Magallón R, Regueiro CA, Romero J, Zapata I, de la Fuente C, Fernández-Lizarbe E, Vergara G, Belinchón B, Veiras M, Molerón R, Millán I.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):102-10. PubMed ID: 17869446
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 01; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 9. UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
    Coşkun U, Kaya AO, Alkis N, Buyukberber S, Alici S, Celenkoglu G, Uncu D, Ozkan M, Sevinc A, Benekli M.
    Onkologie; 2009 Oct 01; 32(10):562-6. PubMed ID: 19816072
    [Abstract] [Full Text] [Related]

  • 10. Phase I trial of uracil-ftorafur, leucovorin, and etoposide: an active all-oral regimen for metastatic breast cancer.
    Hartman AR, Grekowicz A, Lum BL, Carlson RW, Schurman C, Sikic BI, Shapiro R, Stockdale FE.
    Breast Cancer Res Treat; 2003 Nov 01; 82(1):61-9. PubMed ID: 14672404
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.
    Passardi A, Maltoni R, Milandri C, Cecconetto L, Massa I, Zoli W, Tesei A, Fabbri F, Nanni O, Amadori D.
    Oncology; 2007 Nov 01; 72(1-2):118-24. PubMed ID: 18004083
    [Abstract] [Full Text] [Related]

  • 12. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
    Pazdur R, Lassere Y, Diaz-Canton E, Ho DH.
    Cancer Invest; 1998 Nov 01; 16(3):145-51. PubMed ID: 9541627
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
    Bhandari MS, Pienta KJ, Fardig J, Olson K, Smith DC.
    Cancer; 2006 Apr 15; 106(8):1715-21. PubMed ID: 16534795
    [Abstract] [Full Text] [Related]

  • 14. Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
    Surmont V, Aerts JG, Pouw E, Tan KY, Vernhout R, Gras J, Salomé J, Pronk T, Schmitz PI, Hoogsteden H, van Klaveren RJ.
    Lung Cancer; 2009 Dec 15; 66(3):333-7. PubMed ID: 19327865
    [Abstract] [Full Text] [Related]

  • 15. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U, Wilke H, Pari CP, Strumberg D, Harstrick A, Eberhardt W, Becher R, Diergarten K, Seeber S.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [Abstract] [Full Text] [Related]

  • 16. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
    Vormittag L, Kornek GV, Gruhsmann B, Lenauer A, Föger A, Depisch D, Lang F, Scheithauer W.
    Anticancer Drugs; 2007 Jul 15; 18(6):709-12. PubMed ID: 17762401
    [Abstract] [Full Text] [Related]

  • 17. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM, Pazdur R, Benner SE, Canetta R.
    Anticancer Drugs; 1998 Jul 15; 9(6):479-90. PubMed ID: 9877235
    [Abstract] [Full Text] [Related]

  • 18. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
    Sato Y, Inaba Y, Yamaura H, Shimamoto H, Nishiofuku H, Oyama T, Kanemitsu Y, Sawaki A, Arai Y, Muro K.
    Gan To Kagaku Ryoho; 2006 Jul 15; 33(7):887-90. PubMed ID: 16835473
    [Abstract] [Full Text] [Related]

  • 19. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S, Yamaguchi S, Tsuboi K, Fukasawa T, Tabe Y, Asao T, Kuwano H.
    Hepatogastroenterology; 2008 Jul 15; 55(85):1419-22. PubMed ID: 18795703
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E, Karminsky N, Dinerman M, Katsenelson RL, Zvi NB, Baruch NB, Biran H, Man S, Shani A.
    Acta Oncol; 2007 Jul 15; 46(3):324-9. PubMed ID: 17450467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.